Myeloproliferative Neoplasms (MPN) Latest Advances
Find the Latest Research About Myeloproliferative Neoplasms (MPN)
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3005 publications
Mutant ASXL1 exacerbates CALR-mutant myeloproliferative neoplasms by enhancing a distinct megakaryocyte differentiation program.
Journal: The Journal of clinical investigation
Published: October 29, 2026
Constantinescu SN, Vainchenker W, Pecquet C. Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms. Blood. 2026;147(12):1255-1266.
Journal: Blood
Published: October 29, 2026
Modulation of the sensitivity to ruxolitinib-mediated JAK2 inhibition by mutationally activated SHP2 exhibits cell context dependency in pre-clinical models of myeloproliferative neoplasms.
Journal: bioRxiv : the preprint server for biology
Published: October 23, 2026
Calreticulin and myeloproliferative neoplasms: linking biology to targeted therapies.
Journal: Expert review of clinical immunology
Published: October 21, 2026
Myeloproliferative Neoplasms: Finding Our Footing in a Shifting Landscape.
Journal: Seminars in hematology
Published: October 16, 2026
Characterization of Congestive Heart Failure Phenotype in a Murine Model of JAK2V617F-positive Myeloproliferative Neoplasm.
Journal: bioRxiv : the preprint server for biology
Published: October 10, 2026
Aberrant erythrocyte rigidity in JAK2V617F myeloproliferative neoplasms underlies concurrent thrombosis and hemorrhage.
Journal: Science translational medicine
Published: October 07, 2026
Isolated add(12)(p13) in a BCR::ABL1-Negative Neutrophilic Myeloproliferative Neoplasm Lacking Canonical Driver Mutations: A Case Report.
Journal: Cureus
Published: September 30, 2026
Rising myeloproliferative neoplasms in younger patients: preserving future fertility and pregnancies.
Journal: Expert review of hematology
Published: September 28, 2026
Measurable Residual Disease (MRD) Monitoring in Myeloproliferative Neoplasms.
Journal: Cancers
Published: September 28, 2026
Inflammasome, clonal stability and the thrombotic circuit in myeloproliferative neoplasms: an antecedent framework.
Journal: Clinical and experimental medicine
Published: September 20, 2026
Last Updated: 11/08/2026